The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migration

Cell Communication and Signaling

Volumn 12, Issue 1, 2014, Pages

  Mohr, Caroline F ^a   Kalmer, Martina ^a   Gross, Christine ^a   Mann, Melanie C ^a   Sterz, Kai R ^b   Kieser, Arnd ^b,c   Fleckenstein, Bernhard ^a   Kress, Andrea K ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c German Center for Infection Research   (Germany)

Author keywords

CTAR; Epstein Barr virus; Fascin; Invasion; LMP1; Migration; NF B

Indexed keywords

ACTIN BINDING PROTEIN; CARRIER PROTEIN; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; FASCIN; I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX PROTEIN; NF-KAPPAB INHIBITOR ALPHA; ONCOPROTEIN; TUMOR MARKER;

ANTAGONISTS AND INHIBITORS; CELL MOTION; EPSTEIN BARR VIRUS; GENE SILENCING; GENETICS; HUMAN; LYMPHOCYTE; METABOLISM; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION; TRANSFORMED CELL LINE; TUMOR CELL LINE;

CARRIER PROTEINS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL MOVEMENT; GENE KNOCKDOWN TECHNIQUES; HERPESVIRUS 4, HUMAN; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; LYMPHOCYTES; MICROFILAMENT PROTEINS; NF-KAPPA B; ONCOGENE PROTEINS, VIRAL; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL; VIRAL MATRIX PROTEINS;

EID: 84905219315     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/s12964-014-0046-x     Document Type: Article

References (70)

1. Epstein-Barr virus: 40 years on. LS Young, AB Rickinson, Nat Rev Cancer 2004 4 757 768 10.1038/nrc1452 15510157 (Pubitemid 39331148)
2. B cells under influence: transformation of B cells by Epstein-Barr virus. R Kuppers, Nat Rev Immunol 2003 3 801 812 10.1038/nri1201 14523386 (Pubitemid 37328658)
3. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. D Wang, D Liebowitz, E Kieff, Cell 1985 43 831 840 10.1016/0092-8674(85)90256-9 3000618
4. Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. VR Baichwal, B Sugden, Oncogene 1988 2 461 467 2836780
5. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. E Kilger, A Kieser, M Baumann, W Hammerschmidt, EMBO J 1998 17 1700 1709 10.1093/emboj/17.6.1700 9501091 (Pubitemid 28119123)
6. Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae. MM Brinkmann, TF Schulz, J Gen Virol 2006 87 1047 1074 10.1099/vir.0.81598-0 16603506
7. Pursuing different 'TRADDes': TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1. A Kieser, Biol Chem 2008 389 1261 1271 10.1515/BC.2008.144 18713013
8. Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52. PG Atkinson, HJ Coope, M Rowe, SC Ley, J Biol Chem 2003 278 51134 51142 10.1074/jbc.M304771200 14532284 (Pubitemid 38020349)
9. Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines. N Saito, G Courtois, A Chiba, N Yamamoto, T Nitta, N Hironaka, M Rowe, N Yamamoto, S Yamaoka, J Biol Chem 2003 278 46565 46575 10.1074/jbc.M302549200 12968033 (Pubitemid 37452230)
10. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation. M Luftig, T Yasui, V Soni, MS Kang, N Jacobson, E Cahir-McFarland, B Seed, E Kieff, Proc Natl Acad Sci U S A 2004 101 141 146 10.1073/pnas.2237183100 14691250 (Pubitemid 38084217)
11. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. O Devergne, E Hatzivassiliou, KM Izumi, KM Kaye, MF Kleijnen, E Kieff, G Mosialos, Mol Cell Biol 1996 16 7098 7108 8943365 (Pubitemid 26389769)
12. TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1. U Schultheiss, S Puschner, E Kremmer, TW Mak, H Engelmann, W Hammerschmidt, A Kieser, EMBO J 2001 20 5678 5691 10.1093/emboj/20.20.5678 11598011 (Pubitemid 33010045)
13. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. BA Mainou, DN Everly Jr, N Raab-Traub, Oncogene 2005 24 6917 6924 10.1038/sj.onc.1208846 16007144 (Pubitemid 41509414)
14. TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40. AG Eliopoulos, ER Waites, SM Blake, C Davies, P Murray, LS Young, J Virol 2003 77 1316 1328 10.1128/JVI.77.2.1316-1328.2003 12502848 (Pubitemid 36055554)
15. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB. KM Izumi, ED Kieff, Proc Natl Acad Sci U S A 1997 94 12592 12597 10.1073/pnas.94.23.12592 9356494 (Pubitemid 27492573)
16. LMP1 signal transduction differs substantially from TNF receptor 1 signaling in the molecular functions of TRADD and TRAF2. A Kieser, C Kaiser, W Hammerschmidt, EMBO J 1999 18 2511 2521 10.1093/emboj/18.9.2511 10228165 (Pubitemid 29213283)
17. Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6. M Luftig, E Prinarakis, T Yasui, T Tsichritzis, E Cahir-McFarland, J Inoue, H Nakano, TW Mak, WC Yeh, X Li, S Akira, N Suzuki, S Suzuki, G Mosialos, E Kieff, Proc Natl Acad Sci U S A 2003 100 15595 15600 10.1073/pnas.2136756100 14673102 (Pubitemid 38021035)
18. The germinal center kinase TNIK is required for canonical NF-kappaB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor. A Shkoda, JA Town, J Griese, M Romio, H Sarioglu, T Knofel, F Giehler, A Kieser, PLoS Biol 2012 10 1001376 10.1371/journal.pbio.1001376 22904686
19. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. A Kieser, E Kilger, O Gires, M Ueffing, W Kolch, W Hammerschmidt, EMBO J 1997 16 6478 6485 10.1093/emboj/16.21.6478 9351829 (Pubitemid 27483273)
20. Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines. M Birkenbach, D Liebowitz, F Wang, J Sample, E Kieff, J Virol 1989 63 4079 4084 2548016 (Pubitemid 19205490)
21. The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts. D Wang, D Liebowitz, E Kieff, J Virol 1988 62 2337 2346 2836616
22. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. D Wang, D Liebowitz, F Wang, C Gregory, A Rickinson, R Larson, T Springer, E Kieff, J Virol 1988 62 4173 4184 2845129
23. Epstein-Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55-kilodalton actin-bundling protein. G Mosialos, S Yamashiro, RW Baughman, P Matsudaira, L Vara, F Matsumura, E Kieff, M Birkenbach, J Virol 1994 68 7320 7328 7933116 (Pubitemid 24328786)
24. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation? GS Pinkus, JL Pinkus, E Langhoff, F Matsumura, S Yamashiro, G Mosialos, JW Said, Am J Pathol 1997 150 543 562 9033270 (Pubitemid 27073784)
25. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma]. QY Liu, AJ Han, SY You, Y Dong, QX Yang, JH Wu, MF Li, Ai Zheng 2008 27 1070 1076 18851787
26. Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patients. D Krikelis, M Bobos, G Karayannopoulou, L Resiga, S Chrysafi, E Samantas, D Andreopoulos, V Vassiliou, E Ciuleanu, G Fountzilas, BMC Clin Pathol 2013 13 1 10.1186/1472-6890-13-1 23360534
27. Fascin protrusions in cell interactions. JC Adams, Trends Cardiovasc Med 2004 14 221 226 10.1016/j.tcm.2004.06.002 15451513 (Pubitemid 39297019)
28. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Y Hashimoto, M Skacel, JC Adams, Int J Biochem Cell Biol 2005 37 1787 1804 10.1016/j.biocel.2005.05.004 16002322 (Pubitemid 40961664)
29. Fascin: A key regulator of cytoskeletal dynamics. A Jayo, M Parsons, Int J Biochem Cell Biol 2010 42 1614 1617 10.1016/j.biocel.2010.06.019 20601080
30. The tumor marker Fascin is strongly induced by the Tax oncoprotein of HTLV-1 through NF-kappaB signals. AK Kress, M Kalmer, AG Rowan, R Grassmann, B Fleckenstein, Blood 2011 117 3609 3612 10.1182/blood-2010-09-305805 21300980
31. Migrastatin analogues target fascin to block tumour metastasis. L Chen, S Yang, J Jakoncic, JJ Zhang, XY Huang, Nature 2010 464 1062 1066 10.1038/nature08978 20393565
32. A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant. JS Cannon, D Ciufo, AL Hawkins, CA Griffin, MJ Borowitz, GS Hayward, RF Ambinder, J Virol 2000 74 10187 10193 10.1128/JVI.74.21.10187-10193.2000 11024147
33. The viral oncoprotein LMP1 exploits TRADD for signaling by masking its apoptotic activity. F Schneider, J Neugebauer, J Griese, N Liefold, H Kutz, C Briseno, A Kieser, PLoS Biol 2008 6 8 10.1371/journal.pbio.0060008 18198944 (Pubitemid 351226049)
34. Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. U Dirmeier, R Hoffmann, E Kilger, U Schultheiss, C Briseno, O Gires, A Kieser, D Eick, B Sugden, W Hammerschmidt, Oncogene 2005 24 1711 1717 10.1038/sj.onc.1208367 15674340 (Pubitemid 40461127)
35. NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. RE Voll, E Jimi, RJ Phillips, DF Barber, M Rincon, AC Hayday, RA Flavell, S Ghosh, Immunity 2000 13 677 689 10.1016/S1074-7613(00)00067-4 11114380
36. Activation of noncanonical NF-kappaB signaling by the oncoprotein Tio. SJ de Jong, JC Albrecht, M Schmidt, I Muller-Fleckenstein, B Biesinger, J Biol Chem 2010 285 16495 16503 10.1074/jbc.M110.102848 20353939
37. Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation. BE Gewurz, JC Mar, M Padi, B Zhao, NP Shinners, K Takasaki, E Bedoya, JY Zou, E Cahir-McFarland, J Quackenbush, E Kieff, J Virol 2011 85 6764 6773 10.1128/JVI.00422-11 21543491
38. The c-Jun N-terminal kinase pathway is critical for cell transformation by the latent membrane protein 1 of Epstein-Barr virus. H Kutz, G Reisbach, U Schultheiss, A Kieser, Virology 2008 371 246 256 10.1016/j.virol.2007.09.044 17967471 (Pubitemid 351173227)
39. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. ED Cahir-McFarland, K Carter, A Rosenwald, JM Giltnane, SE Henrickson, LM Staudt, E Kieff, J Virol 2004 78 4108 4119 10.1128/JVI.78.8.4108-4119.2004 15047827 (Pubitemid 38437217)
40. NF-kappaB and AP-1 regulate activation-dependent CD137 (4-1BB) expression in T cells. JO Kim, HW Kim, KM Baek, CY Kang, FEBS Lett 2003 541 163 170 10.1016/S0014-5793(03)00326-0 12706838 (Pubitemid 36428936)
41. The roles of fascins in health and disease. Y Hashimoto, DJ Kim, JC Adams, J Pathol 2011 224 289 300 10.1002/path.2894 21618240
42. Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration. K Endo, S Kondo, J Shackleford, T Horikawa, N Kitagawa, T Yoshizaki, M Furukawa, Y Zen, JS Pagano, Oncogene 2009 28 1725 1735 10.1038/onc.2009.20 19234486
43. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion. CH Ho, CL Chen, WY Li, CJ Chen, Carcinogenesis 2009 30 1443 1451 10.1093/carcin/bgp135 19483191
44. EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration. KH Shair, CI Schnegg, N Raab-Traub, Cancer Res 2008 68 6997 7005 10.1158/0008-5472.CAN-08-1178 18757414
45. The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. CN Tsai, CL Tsai, KP Tse, HY Chang, YS Chang, Proc Natl Acad Sci U S A 2002 99 10084 10089 10.1073/pnas.152059399 12110730 (Pubitemid 34831176)
46. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders. W Kempf, E Levi, J Kamarashev, H Kutzner, W Pfeifer, T Petrogiannis-Haliotis, G Burg, ME Kadin, J Cutan Pathol 2002 29 295 300 10.1034/j.1600-0560.2002.290507.x 12100631 (Pubitemid 34828043)
47. The biology of Hodgkin's lymphoma. R Kuppers, Nat Rev Cancer 2009 9 15 27 10.1038/nrc2542 19078975
48. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. RC Bargou, C Leng, D Krappmann, F Emmerich, MY Mapara, K Bommert, HD Royer, C Scheidereit, B Dorken, Blood 1996 87 4340 4347 8639794 (Pubitemid 26155031)
49. Kaposi sarcoma-associated herpesvirus and other viruses in human lymphomagenesis. E Cesarman, EA Mesri, Curr Top Microbiol Immunol 2007 312 263 287 17089801 (Pubitemid 47400340)
50. Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production. N Ahsan, T Kanda, K Nagashima, K Takada, J Virol 2005 79 4415 4424 10.1128/JVI.79.7.4415-4424.2005 15767441 (Pubitemid 40388378)
51. Roles of Cell Signaling Pathways in Cell-to-Cell Contact-Mediated Epstein-Barr Virus Transmission. A Nanbo, H Terada, K Kachi, K Takada, T Matsuda, J Virol 2012 86 9285 9296 10.1128/JVI.00712-12 22718812
52. Epstein-Barr virus latent membrane protein-1 effects on junctional plakoglobin and induction of a cadherin switch. KH Shair, CI Schnegg, N Raab-Traub, Cancer Res 2009 69 5734 5742 10.1158/0008-5472.CAN-09-0468 19584275
53. C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines. A Grothey, R Hashizume, H Ji, BE Tubb, CW Patrick Jr, D Yu, EE Mooney, PD McCrea, Oncogene 2000 19 4864 4875 10.1038/sj.onc.1203838 11039904
54. Signal transducers and activators of transcription 3 (STAT3) directly regulates cytokine-induced fascin expression and is required for breast cancer cell migration. M Snyder, XY Huang, JJ Zhang, J Biol Chem 2011 286 38886 38893 10.1074/jbc.M111.286245 21937440
55. Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. P Kavathas, FH Bach, R DeMars, Proc Natl Acad Sci U S A 1980 77 4251 4255 10.1073/pnas.77.7.4251 6933474 (Pubitemid 10022588)
56. Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease. H Kamesaki, S Fukuhara, E Tatsumi, H Uchino, H Yamabe, H Miwa, S Shirakawa, M Hatanaka, T Honjo, Blood 1986 68 285 292 3013343 (Pubitemid 16033644)
57. A Hodgkin's disease cell line, KM-H2, shows biphenotypic features of dendritic cells and B cells. K Uehira, R Amakawa, T Ito, T Uehira, Y Ozaki, T Shimizu, M Fujimoto, M Inaba, S Fukuhara, Int J Hematol 2001 73 236 244 10.1007/BF02981944 11372738 (Pubitemid 33758867)
58. Establishment of a malignant, Epstein-Barr-virus (EBV)-negative cell-line from the pleura effusion of a patient with Hodgkin's disease. M Schaadt, C Fonatsch, H Kirchner, V Diehl, Blut 1979 38 185 190 10.1007/BF01007965 216443 (Pubitemid 9127754)
59. Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles. HG Drexler, G Gaedicke, MS Lok, V Diehl, J Minowada, Leuk Res 1986 10 487 500 10.1016/0145-2126(86)90084-6 3713248 (Pubitemid 16118153)
60. Characterization of Hodgkin's disease derived cell line HDLM-2. HG Drexler, SM Gignac, AV Hoffbrand, BF Leber, J Norton, MS Lok, J Minowada, Recent Results Cancer Res 1989 117 75 82 10.1007/978-3-642-83781-4-8 2602652
61. Cytology of Burkitt's tumour (African Lymphoma). JV Pulvertaft, Lancet 1964 1 238 240 10.1016/S0140-6736(64)92345-1 14086209
62. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. J Menezes, W Leibold, G Klein, G Clements, Biomedicine 1975 22 276 284 179629
63. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. N Shimizu, A Tanabe-Tochikura, Y Kuroiwa, K Takada, J Virol 1994 68 6069 6073 8057484
64. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. R Renne, W Zhong, B Herndier, M McGrath, N Abbey, D Kedes, D Ganem, Nat Med 1996 2 342 346 10.1038/nm0396-342 8612236 (Pubitemid 26080656)
65. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. L Arvanitakis, EA Mesri, RG Nador, JW Said, AS Asch, DM Knowles, E Cesarman, Blood 1996 88 2648 2654 8839859 (Pubitemid 26327517)
66. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. M Yoshida, I Miyoshi, Y Hinuma, Proc Natl Acad Sci U S A 1982 79 2031 2035 10.1073/pnas.79.6.2031 6979048 (Pubitemid 12088563)
67. Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. U Schneider, HU Schwenk, G Bornkamm, Int J Cancer 1977 19 621 626 10.1002/ijc.2910190505 68013 (Pubitemid 8094638)
68. The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells. E Wies, Y Mori, A Hahn, E Kremmer, M Sturzl, B Fleckenstein, F Neipel, Blood 2008 111 320 327 10.1182/blood-2007-05-092288 17890449
69. Development and characterization of monoclonal antibodies to the HTLV-I Tax (P40X) protein. B Langton, M Sliwkowski, K Tran, S Knapp, E Keitelmann, C Smith, S Wallingford, H-L Liu, J Ralston, J Brandis, S Coates, Med Virol 1988 8 295
70. Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T cells by the viral Tax oncoprotein. K Pichler, T Kattan, J Gentzsch, AK Kress, GP Taylor, CR Bangham, R Grassmann, Blood 2008 111 4741 4751 10.1182/blood-2007-10-115220 18276843